Patents/Assignees

Breakpoint Therapeutics GmbH

2 patents in portfolio

US12162895utility2024
DNA Polymerase Theta Inhibitor for Treatment of Cancer
0 cites
US12145945utility2024
Compounds, Compositions, and Therapeutic Uses Thereof
0 cites